You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inoperable stage III non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

Not yet recruiting
  • NSCLC, Stage III
  • Signatera ctDNA test
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Mar 13, 2023

NSCLC, Stage III Trial (SHR-1701)

Not yet recruiting
  • NSCLC, Stage III
  • (no location specified)
Dec 14, 2021

Non Small Cell Lung Cancer Trial in Philadelphia (Nelfinavir)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 2, 2021

NSCLC, Squamous Cell Carcinoma Trial in Wuhan (Nab-paclitaxel, Carboplatin, Thoracic radiation therapy)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Squamous Cell Carcinoma
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 26, 2022

Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)

Recruiting
  • Oncology
  • +2 more
  • UV1
  • +2 more
  • Drammen, Viken, Norway
    Vestre Viken Health Trust
Aug 15, 2022

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes

Recruiting
  • Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
    • Grozny, Russian Federation
    • +4 more
    May 31, 2023

    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

    Active, not recruiting
    • Adenocarcinoma of the Lung
    • +8 more
    • hypofractionated radiation therapy
    • +5 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Dec 2, 2021

    Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,

    Not yet recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +2 more
    • (no location specified)
    Nov 14, 2022

    NSCLC Trial in Edegem (Metformin, No metformin)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Edegem, Antwerp, Belgium
      University Hospital Antwerp
    Jan 12, 2021

    Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial

    Recruiting
    • Stage II Non-Small Cell Lung Cancer AJCC v7
    • +5 more
    • Jacksonville, Florida
    • +29 more
    Dec 15, 2022

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Hafnium

      Recruiting
      • Recurrent Lung Non-Small Cell Carcinoma
      • +13 more
      • Hafnium Oxide-containing Nanoparticles NBTXR3
      • Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 3, 2021

      NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Sugemalimab and Chemotherapy
      • Changsha, China
        Hunan Cancer Hospital
      Jul 7, 2023

      Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

      Recruiting
      • Nonsmall Cell Lung Cancer
      • +3 more
      • Genomically Guided Radiation Therapy (RT)
      • Tampa, Florida
        Moffitt Cancer Center
      May 23, 2023

      Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

      Recruiting
      • Stage III Non-small-cell Lung Cancer
      • Neoadjuvant therapy
      • +4 more
      • Foshan, Guangdong, China
      • +2 more
      Oct 25, 2022

      Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • (no location specified)
      Jun 3, 2023

      NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Befotertinib + Icotinib placebo
      • Icotinib + Befotertinib placebo
      • Beijing, China
      • +2 more
      Sep 20, 2023

      Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

      Not yet recruiting
      • Stage III NSCLC
      • Surgery
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Feb 21, 2023

      Omitting Clinical Target Volume in Radical Treatment of

      Not yet recruiting
      • Immunotherapy
      • +3 more
      • IMRT+adjuvant immunotherapy
      • (no location specified)
      Jun 9, 2023

      NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
      • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
      • Tianjing, Tianjin, China
        Tianjin cancer hospital
      Nov 3, 2023

      Standard of Care Lifestyle Support for Stage III NSCLC Patients

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Lifestyle advice
      • (no location specified)
      Aug 23, 2022

      NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

      Recruiting
      • Non-small Cell Lung Cancer
      • SH-1028 tablets
      • Placebo SH-1028 tablets
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 6, 2023

      Double-dose Furmonertinib in Treatment of Slow

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • (no location specified)
      Oct 31, 2023

      NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • radiotherapy
      • +3 more
      • (no location specified)
      Sep 10, 2023

      Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

      Not yet recruiting
      • Lung Cancer, Nonsmall Cell
      • Lung Cancer Stage III
      • Nivolumab and Chemotherapy
      • +3 more
      • (no location specified)
      Aug 15, 2023